Novartis Ag (NVS) Total Debt (2016 - 2025)
Historic Total Debt for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $33.5 billion.
- Novartis Ag's Total Debt rose 1330.83% to $33.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $33.5 billion, marking a year-over-year increase of 1330.83%. This contributed to the annual value of $33.5 billion for FY2025, which is 1330.83% up from last year.
- Per Novartis Ag's latest filing, its Total Debt stood at $33.5 billion for Q4 2025, which was up 1330.83% from $30.1 billion recorded in Q3 2025.
- Novartis Ag's 5-year Total Debt high stood at $35.9 billion for Q1 2021, and its period low was $23.5 billion during Q3 2023.
- Moreover, its 5-year median value for Total Debt was $29.4 billion (2022), whereas its average is $29.1 billion.
- In the last 5 years, Novartis Ag's Total Debt tumbled by 1899.62% in 2021 and then soared by 2886.17% in 2024.
- Quarter analysis of 5 years shows Novartis Ag's Total Debt stood at $29.2 billion in 2021, then dropped by 10.35% to $26.2 billion in 2022, then fell by 5.98% to $24.6 billion in 2023, then increased by 20.26% to $29.6 billion in 2024, then rose by 13.31% to $33.5 billion in 2025.
- Its Total Debt was $33.5 billion in Q4 2025, compared to $30.1 billion in Q3 2025 and $30.8 billion in Q2 2025.